Article Listing - Pfizer Gets AAA Ranking From S&P

ICH STEERING COMMITTEE MEETING

6 April 1992

The Steering Committee for the Second International Conference on Harmonization (ICH) of technical requirements for the registration of pharmaceutical products...

STOCK MARKET COMMENTARY: TOKYO

6 April 1992

TOKYO: stocks declined last week after a brief hiatus. The Nikkei Average fell 2.8% to 19,669.311, once again below the...

AUSTRALIAN LAUNCH OF ROCHE'S AURORIX

6 April 1992

Hoffmann-La Roche's reversible inhibitor of monoamine oxidase type A, Aurorix (moclobemide) has now been launched in Australia. The novel antidepressant...

COMPANY NEWS FROM CHINA

6 April 1992

The Shanghai Medicines and Health Products Import and Export Corporation of China exported products worth $150 million in 1991, reports...

NEW PRES AT RHONE-POULENC RORER

6 April 1992

Rhone-Poulenc Rorer Inc has named Manfred Karobath as senior vice president, RPR, and president, RPR Research and Development. He was...

PA CONSULTING GROUP APPOINTMENTS

6 April 1992

Appointed as senior associates for the pharmaceutical industry at PA Consulting Group are Keith Mansford, former chairman of R&D...

FURTHER FALLS FOR DEPRENYL?

6 April 1992

Shares of the Canadian biopharmaceutical company Deprenyl Re-search have recently lost value and could well fall further, according to local...

US HOSPITAL FORMULARY GUIDE

6 April 1992

The American Society of Hospital Pharmacists has released guidelines on formulary system management for its members.

The ASHP notes that in...

GALLUP SURVEYS UK GPs ON HEPATITIS A

6 April 1992

With the recent introduction of its hepatitis A vaccine Havrix to the UK market, SmithKline Beecham has sponsored a Gallup...

GENENTECH REBUFFS ISIS-3 AND AWAITS GUSTO

6 April 1992

With the formal publication in The Lancet last week of the results of the ISIS-3 thrombolytic product trial, the major...